Enoxaparin Sodium Injection
Product Images NDC 72572-280

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 72572-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Eno0j 0000 01)

An instructional line drawing depicting two hands attaching a needle to a syringe. The left hand holds the needle cap, while the right hand holds the syringe, with arrows indicating the direction to connect them. The image is related to preparation for subcutaneous injection.*

FDA Label Image

Figure B (Eno0j 0000 02)

An instructional illustration showing a hand preparing a syringe for injection. The syringe contains liquid medication, with an arrow indicating the direction to push or expel air or liquid from the syringe before administration. This relates to subcutaneous injection technique for Enoxaparin Sodium.*

FDA Label Image

Figure C (Eno0j 0000 03)

An instructional illustration showing a hand administering an injection with a syringe into the skin, demonstrating the subcutaneous injection technique.*

FDA Label Image

Figure D (Eno0j 0000 04)

An instructional illustration showing a hand holding a syringe labeled Enoxaparin Sodium injection. The image highlights the proper thumb motion to expel air or fluid from the syringe before injection, indicated by an arrow pointing outward from the plunger.*

FDA Label Image

Figure E (Eno0j 0000 05)

An instructional illustration depicting a hand disposing of a used needle or syringe into a container labeled 'BIOHAZARD,' indicating proper sharps disposal protocol.*

FDA Label Image

Structural Formula (Eno0j 0000 06)

Chemical structure of Enoxaparin Sodium showing its polysaccharide repeating units, including sodium carboxylate and sulfate groups, with annotations for substituent groups R1 and R2.*

FDA Label Image

Structural Formula (Eno0j 0000 07)

Chemical structure of Enoxaparin Sodium, showing its molecular configuration with functional groups and sodium ions indicated.*

FDA Label Image

Figure (Eno0j 0000 08)

A forest plot chart comparing relative risk between unfractionated heparin (UFH) and Enoxaparin Sodium (Enox) across various patient subgroups. Subgroups are listed by sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent, time to treatment, and PCI status. The chart displays risk percentages for UFH and Enox, with dots indicating relative risk values favoring Enoxaparin or UFH. The overall data includes 20,479 patients.*

FDA Label Image

Figure (Eno0j 0000 09)

A hazard distribution function graph comparing Enoxaparin Sodium injection with UFH over time from day 0 to 30 days, indicating risk of death or myocardial re-infarction. The graph includes number at risk data for both treatments and an inset plot showing hazard distribution at 1 year. It features a log-rank test with p-values demonstrating statistical analysis between Enoxaparin and UFH.*

FDA Label Image

Figure (Eno0j 0000 10)

An instructional diagram showing a syringe labeled 'Before Use' and 'After Use.' The 'Before Use' syringe includes a plunger rod, needle, and needle cap. The 'After Use' syringe shows the plunger rod pushed down with the needle covered by a protective sleeve, illustrating safe needle handling after injection.*

FDA Label Image

Figure (Eno0j 0000 11)

An instructional diagram showing components for subcutaneous injection of Enoxaparin Sodium. It includes a prefilled syringe labeled Enoxaparin sodium, a sharps disposal container, a cotton ball or gauze, an alcohol wipe, and a small adhesive bandage.*

FDA Label Image

Figure (Eno0j 0000 12)

An instructional illustration showing hands removing a protective cover from a syringe prefilled with Enoxaparin Sodium injection. The image depicts the correct handling step before administration via subcutaneous injection.*

FDA Label Image

Figure (Eno0j 0000 13)

An illustration of a prefilled syringe labeled for Enoxaparin Sodium injection, showing the syringe body, plunger, and needle cover. The label area includes a visible expiration date section.*

FDA Label Image

Figure (Eno0j 0000 14)

An instructional illustration of a syringe filled with a clear liquid, showing the plunger and needle assembly. The label "Clear Liquid" points to the fluid inside the syringe, indicating the appearance of the injection solution.*

FDA Label Image

Figure (Eno0j 0000 15)

An instructional illustration showing abdominal sites for subcutaneous injection administration. It depicts the left and right sides of the abdomen with shaded areas indicating recommended injection zones for subcutaneous injections.*

FDA Label Image

Figure (Eno0j 0000 16)

An instructional illustration showing a hand holding a small square object, possibly a swab or pad, applying it to the abdominal area just above the waistline. This likely depicts part of the preparation steps for a subcutaneous injection of Enoxaparin Sodium.*

FDA Label Image

Figure (Eno0j 0000 17)

An instructional illustration showing a pair of hands preparing a syringe. One hand holds the syringe with a cap, and the other hand is pulling the cap away. Arrows indicate the direction to remove the cap from the syringe.*

FDA Label Image

Figure (Eno0j 0000 18)

An instructional illustration showing a hand holding a syringe for injection. The syringe is labeled with a mark indicating "Set your dose," with a downward arrow emphasizing the dosing adjustment. The image visually guides dose setting for the Enoxaparin Sodium injection.*

FDA Label Image

Figure (Eno0j 0000 19)

An instructional line drawing showing a hand with thumb extended, grasping or pinching an area of skin, likely demonstrating the technique for subcutaneous injection.*

FDA Label Image

Figure (Eno0j 0000 20)

Instructional diagram showing a hand administering an Enoxaparin Sodium injection subcutaneously at a 90-degree angle. The syringe is positioned into the skin with an arrow indicating the direction of injection.*

FDA Label Image

Figure (Eno0j 0000 21)

An instructional illustration depicting the subcutaneous injection technique. It shows one hand pinching the skin on the abdomen while the other hand holds a syringe, inserting the needle at an angle into the pinched skin with an arrow indicating the direction of injection.*

FDA Label Image

Figure (Eno0j 0000 22)

An instructional diagram illustrating the subcutaneous injection technique. It shows a hand pinching the abdominal skin and another hand holding a syringe, positioned for injection into the pinched area, with an arrow indicating the direction of needle insertion.*

FDA Label Image

Figure (Eno0j 0000 23)

An instructional diagram showing a hand holding a syringe labeled as having a protective sleeve. An arrow points right with the word 'CLICK,' indicating pressing the plunger or a mechanism for delivery or activation of the injection device.*

FDA Label Image

Figure (Eno0j 0000 24)

An instructional illustration showing the proper disposal of an Enoxaparin Sodium injection syringe by placing the needle cap into a sharps disposal container. The image highlights the syringe and needle cap in relation to the sharps container for safe disposal.*

FDA Label Image

Package Label – Principal Display Panel – Syringe Blister Label (Eno0j 0000 25)

Label for Enoxaparin Sodium Injection, USP showing a strength of 40 mg per 0.4 mL in a single-dose syringe. The label indicates subcutaneous injection as the route and includes the manufacturer information as Civica, Inc. and Sagent Pharmaceuticals. It also features a barcode and storage instructions at 20 to 25°C.*

FDA Label Image

Package Label – Principal Display Panel – Carton (Eno0j 0000 26)

Packaging label for Enoxaparin Sodium Injection, USP 40 mg per 0.4 mL by Civica, Inc. The label indicates single-dose syringes with automatic safety device for subcutaneous injection. Instructions for use and dosing information are included. The label also features storage guidelines and product identification details with the NDC 72572-280-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.